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Abstract: Background and Objectives: Maxillary bone defects related to post-extraction alveolar ridge
resorption are usual. These defects may lead to failure in further surgical implant phases given
the lack of bone volume to perform the dental implant. The objective of this clinical assay was to
evaluate the safety and efficacy of an experimental synthetic bone substitute in the preservation
of post-extraction maxillary alveoli. Materials and Methods: 33 voluntary patients who had at least
one maxillary premolar tooth that was a candidate for exodontia (n = 39) and subsequent implant
rehabilitation participated. The regenerated alveoli were monitored by means of periodic clinical
examinations (days 9 ± 1, 21 ± 4, 42 ± 6, and 84 ± 6), measuring the height and width of the alveolar
crest (days 0 and 180 ± 5), measurement of radiodensity using tomographic techniques (days 0–5 and
175 ± 5), and histological examination of biopsies collected at 180 ± 5 days. Results: No significant
differences were observed during the entire follow-up period between the two groups with respect to
the safety variables studied. A variation in width of −0.9 ± 1.3 mm and −0.6 ± 1.5 mm, and a variation
in height of −0.1 ± 0.9 mm and −0.3 ± 0.7 mm was observed for experimental material Sil-Oss® and
Bio-Oss®, respectively. The radiodensity of the alveoli regenerated with the experimental material
was significantly lower than that corresponding to Bio-Oss®. However, the histological study showed
greater osteoid matrix and replacement of the material with newformed bone in the implanted
beds with the experimental material. Conclusions: Both materials can be used safely and proved
equally effective in maintaining alveolar flange dimensions, they are also histologically biocompatible,
bioactive and osteoconductive. The experimental material showed the advantage of being resorbable
and replaced with newformed bone, in addition to promoting bone regeneration.
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1. Introduction
Maxillary bone defects caused by post-extraction alveolar resorption are among the most common
causes of bone loss. This is a physiological phenomenon that occurs after dental extraction, whereby the
alveolar bone crest becomes reduced in height and original width in amounts that can vary according
to location and individual [1,2]. These defects can hinder the surgical phase of implant treatment due
to insufficient bone volume for the proper placement of dental implants [3–5].
Over the past 20 years, there has been an increasing interest in a concept called “alveolar ridge
preservation”, which is defined as “any procedure undertaken at the time of or after an extraction that
is designed to minimize external resorption of the ridge and maximize bone formation within the
socket [6]”.
In modern dentistry, it is considered that, unless certain measures are taken, this partial atrophy
of the alveolar bone may compromise subsequent rehabilitation [5]. Such measures include the filling
of the post extraction alveoli with autologous bone or bone substitutes, combined or not with the
immediate placement of an intraosseous implant [6–12]. Several authors consider that autologous
bone is the ideal bone substitute, although they also acknowledge the disadvantages of its limited
availability and the need for additional surgery, with all its potential complications [12,13].
As an alternative, a wide variety of bone substitutes of natural or synthetic origin have been
investigated, among them, those derived from equine, bovine or porcine bone, both deproteinized
and demineralized, synthetic calcium phosphate ceramics, and bioglasses [13–18]. However, none
of the currently available commercial bone substitutes have all the desirable characteristics, namely
osteoconductivity, osteoinductivity, and biodegradability. Therefore, the search for the ideal substitute
continues [18]. In this regard, a new biomaterial of synthetic origin has been produced whose biological
behavior is superior to that of other existing fillers. This experimental study material is a synthetic
resorbable granulate composed of monetite (Ca (1 − x) ZnxHPO4 0.01 ≤ x ≤ 0.06), calcium-deficient
hydroxyapatite (Ca10 − x (HPO4) x (PO4) 6 − x (OH) 2 − x) and an amorphous phase consisting of
silica gel ((H2SiO3) n) and calcium phosphates [19]. It has a specific surface area of ≈50 m2/g and an
open intragranular porosity of 60% vol. corresponding to interconnected pores with a diameter in the
range of 0.01–50 µm. Its open interconnected intergranular porosity is 35%, with a pore diameter in the
range of 50–300 µm. In the case of the granulate, particle size is between 0.25 and 1.00 mm. When
implanted, ionic species of Ca, Si, P, and Zn that play a fundamental role in osteogenic processes are
gradually released. The granules of the experimental material are progressively replaced by new bone
formed both outside and inside the granules [19].
The aim of this study was to assess the safety and efficacy of a new bone substitute based on
monetite, silica gel, ps-wollastonite, and a calcium deficient hydroxyapatite implanted in post-extraction
alveolar sockets for the prevention of alveolar ridge resorption.
2. Materials and Methods
2.1. Experimental Design
A double blind randomized, comparative clinical trial was carried out at the Dental Clinic of the
Faculty of Medicine of the University of Salamanca. The design and conduct of the study were in
compliance with the ethical principles of the Declaration of Helsinki and Good Clinical Practice. The
trial protocol was previously approved by the Clinical Research Ethics Committee of the Salamanca
(Internal number SIL-OSS AZ001-CEIC 13/1002, date 25 March 2013) Health Area and by the Spanish
Agency for Medicines and Health Products. All the recruited patients received information about the
characteristics of the treatments they could receive and expressed their voluntary consent in writing.
A total of 33 patients, 13 women and 20 men, participated in the study, all of them in the 29 to
67 age range and randomly distributed into the experimental and control groups. Treatment for each
patient was assigned by a randomization list automatically generated prior to the start of the study in
which the treatment material is determined. In the case of bilateral treatments, treatment was assigned
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to one side or the other, according to a supplementary randomization list. The patient randomization
was performed in order to avoid sex bias, thus the final numbers of men and women in each group
were not significantly different. The patient age range was 25 to 50 years old, in this way we also
limited the effect of estrogen depletion due to menopause. With the results obtained, a table was
prepared, in which the code assigned to each patient was registered, and the assigned regenerative
product. The number of required patients was previously estimated. The calculation was made for a
bidirectional trial, considering a significance level (α) of 0.05 and a study power of 80%. A patient loss
of 15% was considered, expecting a very low rate of subjects withdrawn from the study, due to the
aesthetic, economic, and functional importance of implant and prosthesis placement, as well as the
low incidence of episodes or expected negative effects. The calculation indicated that 30 patients were
needed; 15 for the Bio-Oss group and 15 for Sil-Oss.
The experimental group was treated with the synthetic bone substitute, and the control group
with Bio-Oss® (Geistlich Pharma, Baden-Baden Germany) [20], which consists of bovine-derived
hydroxyapatite. Both the experimental material and Bio-Oss® were used in the form of 0.25–1.00
mm granules.
The main inclusion criterion was the presence of at least one maxillary premolar that was
a candidate for exodontics and subsequent dental implant surgery. The exclusion criteria were:
impossibility to attend follow-up visits; pregnancy and breast-feeding; mental disability that could
affect understanding of the information about the study and of pre- and postoperative care instructions;
HIV or hepatitis carrier state, or any disease, treatment or recent surgery that could interfere with the
study; anticoagulant therapy or treatment with experimental drugs over the last month; smoking more
than five cigarettes a day; dental-bacterial plaque index above 30%; severe bruxism; loss of bone border
during extraction; menopause; bisphosphonate treatment; and expression of the willingness to leave
the study after recruitment.
The final sample consisted of 39 maxillary premolars, of which 20 received the experimental
treatment and 19 were treated with the control material (Bio-Oss®).
2.2. Surgical Procedure
In the area of the tooth to be extracted, an intracrevicular incision was made, minimally extended
to the adjacent teeth, and a mucoperiosteal flap was raised 3–4 mm from the buccal and lingual bone
crest. No vertical incisions were made, the purpose being to preserve as much of the interproximal
papillae as possible. The extraction of the affected tooth was atraumatic, using a periosteal elevator
and trying to preserve the surrounding bone walls.
Careful debridement of the alveolar cavity was performed and filled with the experimental or
control material, as required, previously moistened with physiological serum, and slightly compacted,
taking care not to overfill the cavity beyond the level of the bone table. The area was covered with a
resorbable membrane (Osteobiol® Evolution, Tecnoss, Italy) and, after replacing the flap, trying to
face the edges to the maximum, it was sutured using mattress stitch (Figure 1A). At 180 ± 5 days after
extraction, the area was examined again and subjected to osteoctomy using a 10 mm-long trephine
milling cutter with an inner diameter of 3.5–3.7 mm (Meisinger, Neuss, Germany) to take a biopsy of
the treated alveolar socket and prepare the implant bed (Figure 1B). After inserting the intraosseous
implant, the flap was replaced and the tissue of the central part of the socket, previously filled with the
experimental or control material, was sutured (Figure 1C).
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Figure 1. Clinical sequence surgical procedure. (A) Alveolus curettage after exodontist. (B) Stuffed 
with regenerative material. (C) Suture and closure of the socket. 
2.3. Postsurgical Follow-Up 
All patients received preventive antibiotic therapy (amoxicillin/clavulanic, 500/125 mg, three 
times a day by mouth) during the first eight days after surgery. Postoperative pain was treated with 
paracetamol (1000 mg) every 8 h until its remission. Patients were instructed to avoid brushing the 
affected area and to rinse with 0.12% chlorhexidine twice a day during the first two weeks of the 
postoperative period. Likewise, the use of any removable temporary prosthesis was suspended 
during the first three weeks of the postoperative period, prior assessment and adjustment to relieve 
any possible pressure on the implanted area. Patient follow-up was carried out using flange width 
and height measurements, together with clinical, radiographic, and histological examinations, as 
planned (Table 1). 
Figure 1. Clinical sequence surgical procedure. (A) Alveolus curettage after exodontist. (B) Stuffed
with regenerative material. (C) Suture and closure of the socket.
2.3. Postsurgical Follow-Up
All patients received preventive antibiotic therapy (amoxicillin/clavulanic, 500/125 mg, three
times a day by mouth) during the first eight days after surgery. Postoperative pain was treated with
paracetamol (1000 mg) every 8 h until its remission. Patients were instructed to avoid brushing
the affected area and to rinse with 0.12% chlorhexidine twice a day during the first two weeks of
the postoperative period. Likewise, the use of any removable temporary prosthesis was suspended
during the first three weeks of the postoperative period, prior assessment and adjustment to relieve
any possible pressure on the implanted area. Patient follow-up was carried out using flange width
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and height measurements, together with clinical, radiographic, and histological examinations, as
planned (Table 1).
Table 1. Action protocol carried out for each phase of the study.
Visit Days
Recruitment visit Up to 20 days prior to treatment
Surgical treatment visit. First surgery phase Day 0
Post-operative TAC-visit Day 0–5
Suture withdrawal visit Day 8–10
3 Week follow-up visit Day 21 ± 4
6 week follow-up visit 42 ± 6
12 week Follow-up visit 84 ± 6
TAC visit pre-implant 25 weeks 175 ± 5
Visit Biopsy and placement of implant at 26 weeks. Second stage 180
The radiodensity of the alveoli filled with the experimental and control material was measured
using computed tomography as shown in Figure 2 (PaX-Flex 3D, Vatech, Gyeonggi-do, South Korea).
The cutting plane ran parallel to the palatal vault and the sweep interval was located between
the alveolar ridge and the palate itself, recording and 1.5 mm thick sections with 1 mm spacing.
Section selection and radiodensity measurements were performed using DicomWorks software. The
measurements included total socket depth and the average of the 3 values was calculated. The
radiodensity of the adjacent bone was measured in a section placed 2 mm above the alveolar apex
(Figure 3). The measurements were made at 0–5 days and at 175 ± 5 days.
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Figure 2. Measurements of the remaining alveolar rim performed with a millimeter probe. B-P: 
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of the adjacent mesial tooth; Ddh: height crest cement of the adjacent distal tooth; Pf.B: depth to the 
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edge. 
Figure 2. Measurements of the remaining alveolar rim performed with a millimeter probe. B-P:
palatal–lingual crest width; P-Bw: palatal bone table width; B-Bw: buccal bone board width; M-Da:
alveolus width; M-Dd: width of space betwee teeth (if bot are present); M h: height crest cement of
the adjacent mesial tooth; Ddh: height cr st cement of the adjacent distal tooth; Pf.B: depth to the oral
edge; Pf.P: depth to the palatal edge; Pf.M: depth to the mesial edge; Pf.D: depth to the distal edge.
Medicina 2020, 56, 46 6 of 14
Medicina 2020, 56, x FOR PEER REVIEW 6 of 14 
 
 
Figure 3. Scheme of topographic measurements used. The measurements were made on cuts parallel 
to the palatal vault resulting from dividing the depth of the regenerated socket between four 
equidistant sections: Crestal cut (Cc), Mid cut (Cm), and Apical cut (Ca). A measure is also made on 
the Orthoradial cut (Co). The density of the reference bone is determined from Reference cuts at 2mm 
from the apex of the regenerated alveolus (CRa) and in the same contralateral area (Crc). 
The trephine burs with biopsies taken at day 180 ± 5 were immersed in 4% buffered formalin for 
at least seven days, after which the tissue sample was extracted, trying to preserve its integrity to the 
maximum. The samples were washed with water and subsequently dehydrated by immersion in 
ethanol-water solutions with increasing ethanol concentrations. The dehydrated samples were 
embedded in methyl methacrylate and the sections (5 μm) were stained with Goldner trichrome. 
All the clinical evaluations, namely flange width and height measurements, radiodensity 
measurements and histological analysis, were performed blindly by previously trained and 
calibrated evaluators. 
2.4. Statistical Protocol 
Data processing and statistical treatment were blinded. The statistical analysis consisted of a 
Chi-squared test (χ2) and a t-test performed using IBM SPSS Statistics Version 20 software (SPSS). 
The verified Excel sheet generated by the electronic CRD was used as input to the analysis program. 
The significance threshold was set at p < 0.05. 
3. Results 
The only adverse clinical effects reported for both treatments, as illustrated in Tables 2 and 3, 
respectively, were inflammation and pain, referred during the first follow-up examination (day 9 ± 
1). More than 85% of the patients reported pain and more than 70% exhibited inflammation at such 
point. Both symptoms can be attributed to surgical trauma, since in subsequent follow-ups they had 
completely remitted. The incidence of inflammation and pain was apparently higher in the control 
group, although no statistically significant differences were found (χ2, p > 0.05) between the 
experimental and control groups (Bio-Oss®). 
Table 2. Statistical analysis for Inflammation in both groups. 
Infl. Bio-Oss Exp. Group Total Eb Es O-Eb O-Es O-Es2/Es O-Eb2/Eb χ2 
0 1 6 7 3.410 3.590 −2.410 2.410 1.703 1.618 
4.839 
p > 0.5 
1 17 14 31 15.103 15.897 1.897 −1.897 0.238 0.226 
2 1 0 1 0.487 0.513 0.513 −0.513 0.540 0.513 
Total 19 20 39     2.482 2.358  
Infl.: Inflammation. 
  
Figure 3. Scheme of topographic measurements used. The measurements were made on cuts parallel to
the palatal vault resulting from dividing the depth of the regenerated socket between four equidistant
sections: Crestal cut (Cc), Mid cut (Cm), and Apical cut (Ca). A measure is also made on the Orthoradial
cut (Co). The density of the reference bone is determined from Reference cuts at 2mm from the apex of
the regenerated alveolus (CRa) and in the same contralateral area (Crc).
The trephine burs with biopsies taken at day 180 ± 5 were immersed in 4% buffered formalin
for at least seven days, after hich the tissue sample was extracted, trying to preserve its integrity to
the maximum. The samples ere washed wit water and subsequently dehydrated by immersion
in ethanol-water solutions with increasing ethanol concentrations. The dehy rated samples were
embedded in methyl methacrylate and the sections (5 µm) were stained with Goldner trichrome.
All the clinical evaluations, namely flange width and height measurements, radiodensity
measurements and histological analysis, were performed blindly by previously trained and
calibrated evaluators.
2.4. Statistic l Protocol
Data processing and statistical treatment were blinded. The statistical analysis consisted of a
Chi-squared test (χ2) and a t-test performed using IBM SPSS Statistics Version 20 software (SPSS). The
verified Excel sheet generated by the electronic CRD was used as input to the analysis program. The
significance threshold was set at p < 0.05.
3. Results
The only adverse clinical effects reported for both treatments, as illustrated in Tables 2 and 3,
respectively, were inflammation and pain, referred during the first follow-up examination (day 9 ± 1).
More than 85% of the patients reported pain and more than 70% exhibited inflammation at such
point. Both symptoms can be attributed to surgical trauma, since in subsequent follow-ups they
had completely remitted. The incidence of inflammation and pain was apparently higher in the
control group, although no statistic lly sig ificant differences were found (χ2, p > 0.05) between the
experimental and control groups (Bio-Oss®).
Table 2. Statistical analysis for Inflammation in both groups.
Infl. Bio-Oss Exp. Group Total Eb Es O-Eb O-Es O-Es2/Es O-Eb2/Eb χ2
0 1 6 7 3.410 3.590 −2.410 2.410 1.703 1.618 4.839
p > 0.51 17 14 31 15.103 15.897 1.897 −1.897 0.238 0.226
2 1 0 1 0.487 0.513 0.513 −0.513 0.540 0.513
Total 19 20 39 2.482 2.358
Infl.: Inflammation.
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Table 3. Statistical analysis for Pain in both groups.
Pain Bio-Oss Exp. Group Total Eb Es O-Eb O-Es O-Es2/Es O-Eb2/Eb χ2
0 1 3 4 1.949 2.051 −0.949 0.949 0.462 0.439 1.975
p > 0.51 17 17 34 16.564 17.435 0.436 −0.436 0.011 0.011
2 1 0 1 0.487 0.513 0.513 −0.513 0.540 0.513
Total 19 20 39 1.013 0.963
During the 180 ± 5-day period between the initial and final alveolar flange dimensions
measurements, both treatments yielded a small decrease in both width and height, as shown in
Table 4. Flange width variation was −0.6 ± 1.4 mm in the experimental group and −0.9 ± 1.3 mm in the
control group. In the case of height, the variation detected was −0.3 ± 0.7 mm for the experimental
group and −0.1 ± 0.9 mm for the control group. The values obtained for experimental and control
treatments were similar (no significant difference was detected, Student’s t-test, p > 0.05).
Table 4. Height and width crest variation.
Wide Variation Height Variation
Bio-Oss Experimental Bio-Oss Experimental
Mean ± s.d. −0.88 ± 2.14 −0.57 ± 2.53 −0.125 ± 1.65 −0.312 ± 1.31
t-test; (p) −0.345; 0.732 0.356; 0.724
The degree of radiodensity at the implant sites was higher (p = 0.013) than on the adjacent normal
bone at the two time points analyzed (Figure 4). On the other hand, radiodensity was apparently lower
in the experimental group than in the control group, increasing slightly in both during the follow-up
period, although such increase was not statistically significant (Figure 5).
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Figure 4. Density difference (HU) of alveoli treated with Bio-Oss® (A), and with experimental material
(B). The graphs represent the mean bone density in Housfield (HU) of the regenerated sites regenerated
half alveoli = (Cc + Cm + Ca + Co)/4 and their corresponding reference measures: eans of reference
= (Cra + CRc)/2.
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Figure 5. Difference in HU between Bio-Oss and Experimental group. The Whisker diagram indicating
the median (inside the boxes) ± the first and third quartiles (box limits) and the error bars represented
the mi imum an maximum value. The value represent the diff rence in HU with respect to the
proper bone taken as a refere ce (zero value) represented by the dash d lin .
Figures 6 and 7 show the most significant histological findings regarding the alveoli treated with
the experimental material and with Bio-Oss®, respectively. Histological analysis revealed an invasion
of connective tissue in the coronal area of the biopsies, both in the experimental group and in the
control group. No remnants of the barrier membrane were observed in any case, suggesting that the
invasion of connective tissue could be associated with its rapid resorption. In the alveoli subjected to
the experimental treatment, remains of the material’s granules surrounded by abundant active osteoid
matrix were detected. This was even found inside the gran les s rro n e by connective tissue.
Accordingly, it may be assumed that the osteogenesis process would be induced by the material itself
(Figure 6A,B). Most of the granules of the experimental material become completely osteointegrated by
a process of partial resorption and subsequent replacement by new bone (Figure 6D). The experimental
material is characterized by high intragranular porosity. The presence of pores inside the granules of
the material allow cell colonization and the formation of ossification centers (Figure 6C,D). In addition
to osteogenic activity (Figure 6E), osteoclastic activity ca also be observed, carrying out the desired
bone remodeling process (Figure 6F).
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Figure 6. The granules of the experi ental aterial are surrounded by bone trabeculars deficient in
ineralization which corroborates their osteoforming potential (A,B). It presented greater osteinductive
power, with the formation of osteoblastic ossification (arrows) fr ts at the inter and intragranular
levels (C–E). Additionally, in some of the sampl s, groups of osteoclasts are bserved on the surface,
evidencing the dual resorption presented by this material asterisks denote the presence f ost oclast (F).
On the other hand, the histology of the alveoli that received the control treatment showed little or
no variation in size morphology of the granules of the mat rial, sh wing low resorption. Grea er
ste id ctivity wa observed in t e experimental group than in the control group, and thi oste id
activity may be ssociated with the con ective tissue surrounding the granules, rather than with the
surface of the material. In no case was osteoid matrix observed inside the remaining granules. As i
the experimental group, the granules are osteointegrated in the newly form bone (Figure 7).
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4. Discussion
The use of bone substitutes to produce filling for fresh post-extraction alveoli has been widely
studied, accepting this therapeutic option as ideal to minimize dimensional changes in the alveolar
flange [15,16]. Among the materials used as intra-alveolar bone fillers, autografts, xenografts, or
other types of synthetic fillers have been used [17]. To date, all these bone fillings lack osteogenic
activity, acting only as osteoconductors but maintaining the volume of the defect created after the
exodontia [21].
The purpose of this study was to evaluate the safety and efficacy of the experimental
biomaterial developed compared to Bio-Oss® (Geistlich) in post-extraction alveolar bone regeneration.
Of note, thanks to our study the European Union marking of the product was granted, and it
became commercialized.
The granules of the experimental biomaterial release Ca, P, Si, and Zn ions that stimulate osteogenic
activity in the implant bed, while being gradually resorbed and replaced by newformed bone tissue [22].
Preclinical trials of the experimental material in critical size defects in the proximal tibial epiphysis,
middle femoral epicondyle and greater tubercle of sheep humerus demonstrated intense osteogenic
activity and bone regeneration after 16 weeks [22], which is when the regeneration with new bone of
80% of the defect volume was observed [22].
On the other hand, the control treatment used in the study (Bio-Oss®) is a crystalline hydroxyapatite
granulate obtained from deproteinized bovine bone [23]. Preclinical and clinical evidence confirm that
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Bio-Oss® is osteoconductive, non-absorbable and remains unchanged at the implantation site, even
after 11 years of implantation [23–26].
According to the results obtained in the clinical examinations conducted throughout the follow-up
period, both treatments were highly safe and did not induce any chronic or severe adverse effects.
The statistical analysis of the clinical variables studied (χ2, p < 0.01) yielded no significant differences
between the two bone substitutes.
The reduction of buccolingual and apical-coronal dimensions of the alveolar crest after dental
extraction is a consequence of the bone resorption explained by Wolff’s law, which predicts the
adaptation of bone mass and structure to the intensity and frequency of the mechanical loads it is
subjected to [27]. Bone resorption is greater during the first year, particularly during the first three
months, and up to four times higher in the jaw than in the maxilla. The resorption of the buccal table is
more marked than that of the palatal or lingual table [14]. It has been reported that, within a period of
three months to one year, a height loss of 1.67 mm takes place, while the loss of width is 3.87 mm [28].
According to the results of this study, our experimental material was as effective as Bio-Oss® in
terms of maintaining alveolar dimensions; no statistically significant differences were found (Student’s
t-test p < 0.05), between the two materials regarding alveolar ridge variations in width (experimental
material −0.9 ± 1.3 mm and Bio-Oss® 0.6 ± 1), 5 mm] and height (experimental material 0.1 ± 0.9 mm
and Bio-Oss® 0.3 ± 0.7 mm) after 180 ± 5 days (6 months). The resorption of both materials, was lower
than expected in the absence of treatment [28]. The results indicate that both materials were effective
in preserving the alveolar flange.
The radiodensity of the areas implanted with the experimental material was significantly lower
than that of those treated with Bio-Oss®, both at the beginning and at the end of the follow-up. This
result corresponds to the values of the X-ray linear attenuation coefficient, µ, calculated for both
materials based on their chemical composition and the attenuation coefficients of their components,
µi [29]. The values of µ, calculated for both materials, for X-rays with 70 keV energy, were 1136 cm−1
and 1511 cm−1, respectively, which explains the lower radiopacity observed throughout the study in
the areas treated with the experimental material as compared to those treated with Bio-Oss®.
The biopsies taken from the implanted sites during the placement of the intraosseous implant
(day 180 ± 5; 6 months) allowed a qualitative histological study, which showed bone regeneration
in the alveoli treated with either material. In all cases, the amount of newly formed reticular bone
was greater in the apical region, while, in the coronal region, a greater presence of loose connective
tissue was observed in the remodeling process. These results correspond to the mechanism of bone
regeneration and remodeling of post-extraction alveolar sockets, according to Trombelli et al. [30].
On the other hand, in terms of resorption and osteogenesis, both treatments yielded qualitatively
different results. In the alveoli treated with the experimental material, there were clear signs of its
resorption, specifically, the granules presented a decrease in size and an increase in porosity, always
associated with the replacement of the material with new bone. Against this, there was no decrease in
the size of the Bio-Oss® granules. In addition, the amount of active osteoid matrix was higher in the
implanted sites where the experimental study material had been used. It manifested itself not only
on the surface of the granules, but also inside them, unlike in Bio-Oss® granules, where only a small
osteoid matrix associated with its surface was observed.
According to the above, Bio-Oss® granules showed a purely osteoconductive behavior,
characterized by the deposition of new bone, only on the external surface of the granules of the
material, which remain unchanged and become osteointegrated into the newly formed bone matrix.
On the other hand, in the presence of the experimental material, bone neoformation is associated
with both the external and the internal surface (interconnected porosity) of the granules, which were
remodeled and replaced by new bone, so it could be said that, in addition to being osteoconductive, it
stimulates osteogenesis mechanisms. 180 ± 5 days after the extraction and alveolar sockets treatment,
both materials allowed the insertion of an intraosseous implant in the regenerated bone. Although it will
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be the subject of future studies, it can be stated that implanted patient evolution was favorable in both
treatment groups after more than one year since the extraction and regeneration of the alveolar socket.
5. Conclusions
Both the tried and the control materials (Bio-Oss®) behaved similarly with regard to the safety
variables studied: fever, pain, inflammation, suppuration and exudation of the material. No adverse
effects were reported, which shows that both can be used safely. Both were equally effective in
maintaining alveolar flange dimensions. However, and although our study contributed to obtain the
approval for Sil-Oss© commercialization, we believe that long-term studies might be designed to
reassure its safety and efficacy. The radiographic density of the alveoli implanted with the experimental
material was significantly lower than that of the alveoli implanted with Bio-Oss®, both at the beginning
and at the end of the follow-up period, due to the lower intrinsic radiopacity values of the experimental
material. Both the experimental material and Bio-Oss® proved histologically biocompatible, bioactive
and osteoconductive. The study material induced more osteoid matrix and was largely replaced by
newformed bone. The experimental material is just as effective as Bio-Oss® in maintaining the alveolar
flange, with the advantage of being resorbable and replaced with newformed bone, in addition to
promoting bone regeneration.
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